BR9202321A - Composto,composicao farmaceutica e processo para a preparacao de tal composto - Google Patents

Composto,composicao farmaceutica e processo para a preparacao de tal composto

Info

Publication number
BR9202321A
BR9202321A BR929202321A BR9202321A BR9202321A BR 9202321 A BR9202321 A BR 9202321A BR 929202321 A BR929202321 A BR 929202321A BR 9202321 A BR9202321 A BR 9202321A BR 9202321 A BR9202321 A BR 9202321A
Authority
BR
Brazil
Prior art keywords
hydrogen
alkyl
compound
chem
independently
Prior art date
Application number
BR929202321A
Other languages
English (en)
Portuguese (pt)
Inventor
Gary Paul Stack
Magid Abdel-Megid Abou-Gharbia
Terrance Harold Andree
Noreen Theresa Scherer
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/719,887 external-priority patent/US5126366A/en
Priority claimed from US07/719,882 external-priority patent/US5166367A/en
Application filed by American Home Prod filed Critical American Home Prod
Publication of BR9202321A publication Critical patent/BR9202321A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Insulators (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Light Receiving Elements (AREA)
BR929202321A 1991-06-21 1992-06-19 Composto,composicao farmaceutica e processo para a preparacao de tal composto BR9202321A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/719,887 US5126366A (en) 1991-06-21 1991-06-21 Aminophenoxyalkyl derivatives of benzodioxan
US07/719,882 US5166367A (en) 1991-06-21 1991-06-21 Antipsychotic benzodioxan derivatives

Publications (1)

Publication Number Publication Date
BR9202321A true BR9202321A (pt) 1993-01-19

Family

ID=27110156

Family Applications (1)

Application Number Title Priority Date Filing Date
BR929202321A BR9202321A (pt) 1991-06-21 1992-06-19 Composto,composicao farmaceutica e processo para a preparacao de tal composto

Country Status (19)

Country Link
EP (1) EP0520674B1 (enExample)
JP (1) JP3095533B2 (enExample)
KR (1) KR930000496A (enExample)
AT (1) ATE126515T1 (enExample)
AU (1) AU644743B2 (enExample)
BR (1) BR9202321A (enExample)
CZ (1) CZ281049B6 (enExample)
DE (1) DE69204117T2 (enExample)
DK (1) DK0520674T3 (enExample)
ES (1) ES2076691T3 (enExample)
FI (1) FI922880L (enExample)
GR (1) GR3018111T3 (enExample)
HU (1) HUT61739A (enExample)
IL (1) IL102137A (enExample)
MX (1) MX9203109A (enExample)
NZ (1) NZ243194A (enExample)
PH (1) PH30817A (enExample)
RU (1) RU2056417C1 (enExample)
TW (1) TW203047B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5235055A (en) * 1992-09-02 1993-08-10 American Home Products Corporation Antipsychotic quinoline derivatives of benzodioxanmethylamine
DE10029371A1 (de) * 2000-06-20 2002-01-03 Merck Patent Gmbh Heterocyclische Aminoalkylpyridinderivate als Psychopharmaka
RU2372344C2 (ru) * 2004-05-05 2009-11-10 Ф. Хоффманн-Ля Рош Аг Арилсульфонилбензодиоксаны, применяемые для модуляции 5-нт6 рецептора, 5-нт2a рецептора или и того, и другого
KR102021281B1 (ko) * 2018-05-25 2019-09-16 한국 한의학 연구원 프락신을 유효성분으로 포함하는 우울증 및 불안장애 예방, 개선 또는 치료용 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1100960A (en) 1963-06-20 1968-01-31 Ward Blenkinsop & Co Ltd 1,4-benzodioxane derivatives
US4701456A (en) * 1984-09-19 1987-10-20 Warner-Lambert Company Aminoalkoxybenzopyranones as antipsychotic and anxiolytic agents

Also Published As

Publication number Publication date
FI922880A0 (fi) 1992-06-18
JPH05194481A (ja) 1993-08-03
DE69204117D1 (de) 1995-09-21
TW203047B (enExample) 1993-04-01
EP0520674B1 (en) 1995-08-16
DE69204117T2 (de) 1996-03-14
FI922880A7 (fi) 1992-12-22
JP3095533B2 (ja) 2000-10-03
CZ182392A3 (en) 1993-01-13
FI922880L (fi) 1992-12-22
MX9203109A (es) 1993-06-01
CZ281049B6 (cs) 1996-06-12
PH30817A (en) 1997-10-17
KR930000496A (ko) 1993-01-15
DK0520674T3 (da) 1996-01-08
IL102137A0 (en) 1993-01-14
IL102137A (en) 1996-07-23
RU2056417C1 (ru) 1996-03-20
HUT61739A (en) 1993-03-01
GR3018111T3 (en) 1996-02-29
AU1842692A (en) 1992-12-24
AU644743B2 (en) 1993-12-16
EP0520674A1 (en) 1992-12-30
ES2076691T3 (es) 1995-11-01
HU9202060D0 (en) 1992-09-28
NZ243194A (en) 1993-10-26
ATE126515T1 (de) 1995-09-15

Similar Documents

Publication Publication Date Title
PT82610B (pt) Processo para a preparacao de tiazolidino-dionas hipoglicemicas
BR9811022A (pt) Composto, composição farmacêutica, e, processo para preparação de um composto
NO942953L (no) 11-benzaldoksimestradienderivater, fremgangsmåte for deres fremstilling smat legemddel inneholdende slike
BR9404831A (pt) Composto,formulação farmacêutica e processo de preparação de um composto
IL83842A0 (en) Benzo-fused cycloalkane and exa-and thia-,cycloalkane trans-1,2-diamine derivatives,their preparation and pharmaceutical compositions containing them
DE3587148D1 (de) Indolsaeureverbindungen und ihre anwendung als antiallergische heilmittel.
BR1100379A (pt) Composto, uso de um composto, preparação farmacêutica e processo para preparação de um composto
ATE212860T1 (de) Eine neuartige medizinische verwendung eines 5ht 3-antagonisten
ZA936658B (en) Benzopyran compounds process for their preparation and the pharmaceutical compositions which contain them
MX9803455A (es) Derivados de indolalquilo de benzodioxanmetilamina como ligandos del receptor 5-ht1a.
IT1228288B (it) Composti ad attivita' antiserotoninica
PT99051A (pt) Processo para a preparacao de formoterol e de compostos com ele relacionados e seus derivados
CA2071669A1 (en) Aminophenoxyalkyl derivatives of benzodioxan
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
AU644743B2 (en) Antipsychotic benzodioxan derivatives
BR9611276A (pt) Composto formulação farmacêutica processo para tratamento ou profilaxia de doenças ou condições de seres humanos e uso de um composto
BR9814495A (pt) Composto, processo para prepará-lo, uso do mesmo, composição farmacêutica, e, processo
PT91203A (pt) Processo para a preparacao de novos derivados de antibioticos bu-3608 e de composicoes farmaceuticas que os contem
US5378844B1 (en) 8-(1-aminocycloalkyl)-1,3-dialkylxanthine derivatives preparation process and antidepressant nootropic and psychostimulant composition thereof
MX9305337A (es) Derivados de quinolina de benzodioxanmetilamina con actividad antipsicotica.
GR3002884T3 (en) Substituted chinoxalyl-imidazolidine-2,4-diones, process for their preparation, their use as medicaments and pharmacological preparations
PT98275A (pt) Processo para a preparacao de polimetileno-iminas dissubstituidas
GB8608893D0 (en) D-nor-7-ergoline derivatives
DE3781456D1 (de) Pharmazeutische zusammensetzung, die eine 8-chlor-benzothiazepin-verbindung enthaelt und ihre verwendung.
DE3666588D1 (en) Spiroûbenzofuran-2(3h), 1'cycloheptane¨s, a process and intermediates for their preparation and their use as medicaments

Legal Events

Date Code Title Description
EE Request for examination
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
HIFC Refusal cancelled
FC Decision: refusal